Evidence map›Paper›PMID 35661750›Full record

ArticleScientific reports2022

Variant-driven early warning via unsupervised machine learning analysis of spike protein mutations for COVID-19.

Adele de Hoffer, Shahram Vatani, Corentin Cot, Giacomo Cacciapaglia, Maria Luisa Chiusano, Andrea Cimarelli, Francesco Conventi, Antonio Giannini, Stefan Hohenegger, Francesco Sannino

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. VariantHunter: a method and tool for fast detection of emerging SARS-CoV-2 variants.Database : the journal of biological databases and curation · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adele de Hoffer *Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129, Turin, Italy.
Shahram Vatani *Institut de Physique des 2 Infinis (IP2I), UMR5822, CNRS/IN2P3, 69622, Villeurbanne, France.
Corentin Cot *Laboratoire de Physique des 2 Infinis Irène Joliot Curie (UMR 9012), CNRS/IN2P3, 15 Rue Georges Clemenceau, 91400, Orsay, France.
Giacomo CacciapagliaInstitut de Physique des 2 Infinis (IP2I), UMR5822, CNRS/IN2P3, 69622, Villeurbanne, France. g.cacciapaglia@ipnl.in2p3.fr.
Maria Luisa ChiusanoDepartment of Agricultural Sciences, Università degli Studi di Napoli Federico II, 80055, Portici, Italy.
Andrea CimarelliCentre International de Recherche en Infectiologie (CIRI), Inserm, U1111, CNRS, UMR5308, ENS de Lyon, Univ Lyon, Université Claude Bernard Lyon 1, 46 Allée d'Italie, 69007, Lyon, France.
Francesco ConventiINFN Sezione di Napoli, Complesso Universitario di Monte S. Angelo Edificio 6, Via Cintia, 80126, Naples, Italy.
Antonio GianniniUniversity of Science and Technology of China (USTC), No.96, JinZhai Road, Baohe District, Hefei, 230026, Anhui, China.
Stefan HoheneggerInstitut de Physique des 2 Infinis (IP2I), UMR5822, CNRS/IN2P3, 69622, Villeurbanne, France.
Francesco SanninoScuola Superiore Meridionale, Largo S. Marcellino 10, 80138, Naples, Italy. sannino@cp3.sdu.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Never before such a vast amount of data, including genome sequencing, has been collected for any viral pandemic than for the current case of COVID-19. This offers the possibility to trace the virus evolution and to assess the role mutations play in its spread within the population, in real time. To this end, we focused on the Spike protein for its central role in mediating viral outbreak and replication in host cells. Employing the Levenshtein distance on the Spike protein sequences, we designed a machine learning algorithm yielding a temporal clustering of the available dataset. From this, we were able to identify and define emerging persistent variants that are in agreement with known evidences. Our novel algorithm allowed us to define persistent variants as chains that remain stable over time and to highlight emerging variants of epidemiological interest as branching events that occur over time. Hence, we determined the relationship and temporal connection between variants of interest and the ensuing passage to dominance of the current variants of concern. Remarkably, the analysis and the relevant tools introduced in our work serve as an early warning for the emergence of new persistent variants once the associated cluster reaches 1% of the time-binned sequence data. We validated our approach and its effectiveness on the onset of the Alpha variant of concern. We further predict that the recently identified lineage AY.4.2 ('Delta plus') is causing a new emerging variant. Comparing our findings with the epidemiological data we demonstrated that each new wave is dominated by a new emerging variant, thus confirming the hypothesis of the existence of a strong correlation between the birth of variants and the pandemic multi-wave temporal pattern. The above allows us to introduce the epidemiology of variants that we described via the Mutation epidemiological Renormalisation Group framework.

Indexed as

COVID-19HumansMutationSARS-CoV-2Spike Glycoprotein, CoronavirusUnsupervised Machine LearningSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35661750
PMCPMC9166699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.